A weekly discussion of all things biotech – breaking news, data, deals, and FDA actions – with a community of biotech industry leaders and experts. Join the live streams hosted by @BiotechCH, @daphnezohar, @bradloncar and @biotech1 on Twitter Spaces every Friday at 12pm ET.
Biotech Hangout
Claim This Podcastby Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
4.6(68 reviews)
154 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
56
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality74
Social0
YouTube0
Engagement97
Podcast Overview
A weekly discussion of all things biotech – breaking news, data, deals, and FDA actions – with a community of biotech industry leaders and experts. Join the live streams hosted by @BiotechCH, @daphnezohar, @bradloncar and @biotech1 on Twitter Spaces every Friday at 12pm ET.
Language
🇺🇲
Publishing Since
5/21/2021
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
56
Podcast Authority
BetaFairBased on show quality, social media presence, reviews, charts, and more
Quality74
Social0
YouTube0
Engagement97
7
Excellent Areas
3
Good Performance
9
Growth Opportunities
excellent
Episode Length
59 minutes
Performing excellently!
good
Publishing Consistency
Every 13 days
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for Biotech Hangout
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 29, 2026
Episode 184 - May 29, 2026
Chris Garabedian and Brian Skorney interview Ginkgo Bioworks CEO Jason Kelly about biopharma market trends, China's genetic engineering strategy, and significant industry deals, offering insights into U.S. innovation and global collaboration.
May 15, 2026
Episode 183 - May 15, 2026
Sam Fazeli and Josh Schimmer interview Eric Schmidt and Tess Cameron about biotech deals, China's drug development advantages, FDA leadership changes, and recent clinical trial updates.
May 8, 2026
Episode 182 - May 8, 2026
<p>On this week’s episode, Josh Schimmer, Paul Matteis, Eric Schmidt, Yaron Werber, and special guest STAT’s Allison DeAngelis open with what they describe as “a bananas week for biotech,” highlighting strong substantial secondary offerings, including Cytokinetics and Avalo Therapeutics. The conversation then turns to M&A, with multiple new deals announced in Q1 and continued activity this week, including UCB’s acquisition of Candid Therapeutics for up to $2.2B, Angelini’s $4.1B purchase of Catalyst Pharmaceuticals, and Bayer’s acquisition of Perfuse for up to $2.45B. The group also reflects on what feels like the year of developmental-stage biotech, highlighting investor focus on companies with pipeline events such as Vertex and Biogen, while commercial-stage companies have lagged. In regulatory news, the co-hosts discuss Sanofi’s decision to withdraw diabetes drug, teplizumab, from the Commissioner’s National Priority Review program, broader concerns about shifting goalposts and political influence, and contradicting outcomes including Replimune’s rejection versus Atara’s reversal. On the data front, the hosts discuss Cytokinetics’ Phase 3 results and subsequent $650M raise, as well as encouraging autoimmune data from Artiva Biotherapeutics. They also overview neurofilament as a biomarker following Clene’s data, and J&J’s decision to advance its DUET program despite failing to meet its primary endpoint in IBD. *This episode aired on May 8, 2026.</p>
154 total episodes available with 35 transcripts
Recent guests on Biotech Hangout
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Jason Kelly
Guest
Sam Fazeli
Guest
Josh Schimmer
Guest
Paul Matteis
Guest
Graig Suvannavejh
Guest
Adam Feuerstein
Guest
Eric Schmidt
Guest
Luba Greenwood
Guest
Allison DeAngelis
Guest
Drew Armstrong
Guest
Brian Skorney
Guest
Yaron Werber
Guest
Similar Podcasts
Discover related shows you might enjoy
BioCentury This Week
BioCentury
The Readout Loud
STAT
The Long Run with Luke Timmerman
Timmerman Report
Biotech 2050 Podcast
Biotech 2050
Business Of Biotech
Ben Comer
The BioCentury Show
BioCentury
Cheeky Pint
Stripe
Invest Like the Best with Patrick O'Shaughnessy
Colossus | Investing & Business Podcasts
a16z Podcast
Andreessen Horowitz
Nature Podcast
Springer Nature Limited
Capital Allocators – Inside the Institutional Investment Industry
Ted Seides – Allocator and Asset Management Expert
All-In with Chamath, Jason, Sacks & Friedberg
All-In Podcast, LLC
Odd Lots
Bloomberg
BiotechTV - News
BiotechTV
EconTalk
Russ Roberts
Deep-dive analytics for Biotech Hangout
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Biotech Hangout?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.